DanCann Pharma A/S (NGM: DANCAN)
Sweden
· Delayed Price · Currency is SEK · Price in DKK
0.0116
+0.0060 (107.14%)
At close: Nov 22, 2024
DanCann Pharma Balance Sheet
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | -0.71 | 2.01 | 10.75 | 7.74 | 21.33 | 0.18 |
Cash & Short-Term Investments | -0.71 | 2.01 | 10.75 | 7.74 | 21.33 | 0.18 |
Cash Growth | - | -81.34% | 38.97% | -63.74% | 11791.01% | - |
Accounts Receivable | 5.95 | - | 1.61 | 0.53 | - | - |
Other Receivables | 1.18 | 0.41 | 3.14 | 8.64 | 7.57 | 0.09 |
Receivables | 7.13 | 0.41 | 4.75 | 9.17 | 7.57 | 0.09 |
Inventory | 0.34 | 0.34 | 0.34 | 0.27 | 0.01 | - |
Prepaid Expenses | 0.58 | 0.44 | 0.47 | 0.48 | 0.66 | - |
Other Current Assets | - | -0 | - | - | - | 0.02 |
Total Current Assets | 7.34 | 3.19 | 16.31 | 17.65 | 29.57 | 0.47 |
Property, Plant & Equipment | 3.57 | 3.94 | 9.28 | 9.57 | 3.98 | 0.06 |
Goodwill | 9.3 | 9.95 | 11.22 | 12.5 | - | - |
Other Intangible Assets | - | - | 36.56 | 28.95 | 15.68 | 0.95 |
Other Long-Term Assets | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | - |
Total Assets | 20.53 | 17.39 | 73.7 | 68.99 | 49.55 | 1.47 |
Accounts Payable | 1.74 | 1.09 | 2.75 | 2.92 | 2.82 | 0.1 |
Short-Term Debt | - | 5.91 | 7.56 | - | - | - |
Current Portion of Leases | - | - | - | - | 0.19 | - |
Current Income Taxes Payable | - | - | - | 0.35 | - | - |
Other Current Liabilities | 12.45 | 0.88 | 0.6 | 11.38 | 0.86 | 2 |
Total Current Liabilities | 14.18 | 7.89 | 10.9 | 14.65 | 3.87 | 2.1 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.97 | 1.34 | - |
Other Long-Term Liabilities | - | - | - | - | 0.02 | - |
Total Liabilities | 14.18 | 7.89 | 10.9 | 15.62 | 5.23 | 2.1 |
Common Stock | 1.67 | 5.31 | 2.44 | 1 | 0.78 | 0 |
Retained Earnings | 4.68 | 4.2 | 60.36 | 52.38 | 43.55 | -0.63 |
Shareholders' Equity | 6.35 | 9.51 | 62.79 | 53.37 | 44.33 | -0.63 |
Total Liabilities & Equity | 20.53 | 17.39 | 73.7 | 68.99 | 49.55 | 1.47 |
Total Debt | - | 5.91 | 7.56 | - | 0.19 | - |
Net Cash (Debt) | -0.71 | -3.91 | 3.19 | 7.74 | 21.15 | 0.18 |
Net Cash Growth | - | - | -58.71% | -63.42% | 11687.89% | - |
Net Cash Per Share | -0.00 | -0.03 | 0.05 | 0.34 | 2.39 | - |
Filing Date Shares Outstanding | 1,206 | 141.63 | 65.01 | 26.55 | 20.73 | - |
Total Common Shares Outstanding | 1,206 | 141.63 | 65.01 | 26.55 | 20.73 | - |
Working Capital | -6.85 | -4.7 | 5.41 | 3 | 25.7 | -1.63 |
Book Value Per Share | 0.01 | 0.07 | 0.97 | 2.01 | 2.14 | - |
Tangible Book Value | -2.96 | -0.44 | 15.02 | 11.92 | 28.64 | -1.57 |
Tangible Book Value Per Share | -0.00 | -0.00 | 0.23 | 0.45 | 1.38 | - |
Machinery | - | 3.6 | 3.6 | 3.43 | 1.84 | 0.03 |
Construction In Progress | - | 0.1 | 3.35 | 3.32 | 1.95 | - |
Leasehold Improvements | - | 3.94 | 3.93 | 3.46 | 0.29 | 0.04 |
Source: S&P Capital IQ. Standard template. Financial Sources.